<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01359995</url>
  </required_header>
  <id_info>
    <org_study_id>201010033R</org_study_id>
    <nct_id>NCT01359995</nct_id>
  </id_info>
  <brief_title>Topical Ganciclovir in Patients Receiving Penetrating Keratoplasty With Cytomegalovirus Endotheliitis</brief_title>
  <official_title>Topical Ganciclovir in Patients Receiving Penetrating Keratoplasty With Cytomegalovirus Endotheliitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to evaluate the outcomes of topical ganciclovir in patients
      with cytomegalovirus endotheliitis receiving penetrating keratoplasty at National Taiwan
      University hospital.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, we recruit 7 immunocompetent patients with unexplained graft failures, which
      mimicked herpetic anterior uveitis and graft rejection initially, were diagnosed as CMV
      endotheliitis after aqueous tapping for CMV polymerase chain reaction (PCR). Topical
      ganciclovir was used to control and prevent the reactivation of CMV without systemic
      application and their clinical courses were presented after this treatment modality.

      The purpose of this study was to evaluate the outcomes of topical ganciclovir in patients
      with cytomegalovirus endotheliitis receiving penetrating keratoplasty at National Taiwan
      University hospital.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">November 2011</completion_date>
  <primary_completion_date type="Anticipated">November 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>clinical courses before and after topical ganciclovir in patients with CMV endotheliitis</measure>
    <time_frame>participants will be monitored after receiving topical ganciclovir,an expected average of 1 year</time_frame>
    <description>evaluations including aqueous PCR for CMV, endothelium cell density on confocal microscopy,degree of anterior chamber inflammation..</description>
  </primary_outcome>
  <enrollment type="Anticipated">7</enrollment>
  <condition>Cytomegalovirus Endotheliitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        4 men, 3 women, aged 40-90 years old
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  immunocompetent patients with positive results of the CMV PCR (polymerase chain
             reaction) from aqueous humor tapping receiving penetrating keratoplasty

        Exclusion Criteria:

          -  patients receiving systemic or intravitreal ganciclovir before topical ganciclovir use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>I-Jong Wang, M.D. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>I-Jong Wang, M.D. PhD</last_name>
    <phone>886-23123456</phone>
    <phone_ext>65729</phone_ext>
    <email>ijong@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>I-Jong Wang, M.D. PhD</last_name>
      <phone>886-23123456</phone>
      <phone_ext>65729</phone_ext>
      <email>ijong@ms8.hinet.net</email>
    </contact>
    <investigator>
      <last_name>I-Jong Wang, M.D. PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Koizumi N, Suzuki T, Uno T, Chihara H, Shiraishi A, Hara Y, Inatomi T, Sotozono C, Kawasaki S, Yamasaki K, Mochida C, Ohashi Y, Kinoshita S. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology. 2008 Feb;115(2):292-297.e3. Epub 2007 Jul 31.</citation>
    <PMID>17669498</PMID>
  </reference>
  <reference>
    <citation>Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008 May;145(5):834-40. doi: 10.1016/j.ajo.2007.12.015. Epub 2008 Feb 6.</citation>
    <PMID>18255045</PMID>
  </reference>
  <reference>
    <citation>Anshu A, Chee SP, Mehta JS, Tan DT. Cytomegalovirus endotheliitis in Descemet's stripping endothelial keratoplasty. Ophthalmology. 2009 Apr;116(4):624-30. doi: 10.1016/j.ophtha.2008.10.031. Epub 2009 Feb 4.</citation>
    <PMID>19195708</PMID>
  </reference>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2011</study_first_submitted>
  <study_first_submitted_qc>May 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2011</study_first_posted>
  <last_update_submitted>May 23, 2011</last_update_submitted>
  <last_update_submitted_qc>May 23, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 25, 2011</last_update_posted>
  <responsible_party>
    <name_title>I-Jong Wang</name_title>
    <organization>Department of Ophthalmology</organization>
  </responsible_party>
  <keyword>cytomegalovirus endotheliitis</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ganciclovir</mesh_term>
    <mesh_term>Ganciclovir triphosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

